A detailed history of Scientech Research LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Scientech Research LLC holds 2,238 shares of LLY stock, worth $1.78 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,238
Previous 1,182 89.34%
Holding current value
$1.78 Million
Previous $1.07 Billion 85.27%
% of portfolio
0.39%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $815,379 - $1.01 Million
1,056 Added 89.34%
2,238 $1.98 Billion
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $969,876 - $1.22 Million
-1,338 Reduced 53.1%
1,182 $1.07 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $1.49 Million - $2 Million
2,520 New
2,520 $1.96 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.